Integral Ad Science Holding CORP Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
Vista Equity Partners entities disposed of over 65 million shares of Integral Ad Science common stock at $10.30 per share following a merger where IAS became a wholly-owned subsidiary.
NASDAQ
Atlas Venture Fund VIII, L.P. and its affiliates disposed of all their 22.7 million shares in Integral Ad Science Holding Corp. following its merger into a wholly-owned subsidiary of Igloo Group Parent, Inc. for $10.30 per share.
NASDAQ
Integral Ad Science Director Robert Lord disposed of 29,184 shares of common stock at $10.30 per share as part of a merger agreement where the company became a wholly-owned subsidiary.
NASDAQ
Integral Ad Science CFO Alpana Wegner disposed of 525,279 shares of common stock at $10.30 per share following the company's merger into a wholly-owned subsidiary.
NASDAQ
Integral Ad Science Holding Corp. Director Jill Putman disposed of all common stock holdings following the company's merger into a wholly-owned subsidiary.
NASDAQ
Integral Ad Science Holding Corp.'s Chief Accounting Officer, Alexis Gil II, disposed of 136,840 common shares and converted 131,910 unvested RSUs into cash awards following a merger at $10.30 per share.
NASDAQ
Integral Ad Science CEO Lisa Utzschneider reports changes in beneficial ownership following the company's merger with Igloo Group Parent, Inc.
NASDAQ
Integral Ad Science Director Otto Berkes disposed of 80,601 shares, including RSUs, as the company was acquired for $10.30 per share in cash.
NASDAQ
Director Bridgette P Heller disposed of 62,661 shares of Integral Ad Science Holding Corp. common stock at $10.30 per share due to a merger.
NASDAQ
Integral Ad Science Holding Corp.'s Chief Accounting Officer, Alexis Gil II, sold 2,781 shares of common stock to cover tax liabilities.
NASDAQ
Integral Ad Science CEO Lisa Utzschneider sold 12,180 shares of common stock on November 5, 2025, to cover tax liabilities from stock unit settlement under a pre-arranged plan.
NASDAQ
Integral Ad Science CEO Lisa Utzschneider acquired 23,893 shares of common stock through the vesting of market stock units.
NASDAQ
Integral Ad Science CEO Lisa Utzschneider sold 9,264 shares of common stock at a weighted average price of $10.19 to cover tax liabilities from market stock unit settlement.
NASDAQ
Integral Ad Science Holding Corp.'s Chief Accounting Officer, Gil Alexis II, sold 3,527 shares of common stock for $10.18 per share pursuant to a Rule 10b5-1 trading plan.
NASDAQ
Integral Ad Science CEO Lisa Utzschneider sold 17,267 shares of common stock for tax obligations after the vesting of market stock units.
NASDAQ
Integral Ad Science's Chief Accounting Officer, Alexis Gil II, sold 1,992 shares of common stock to cover tax liabilities from restricted stock unit settlement.
NASDAQ
Integral Ad Science CEO Lisa Utzschneider acquired 33,870 shares of common stock through the vesting of market stock units.
NASDAQ
Integral Ad Science Holding Corp.'s Chief Accounting Officer, Alexis Gil II, sold 25,901 shares of common stock for a weighted average price of $10.18 per share under a pre-arranged trading plan.
NASDAQ
Integral Ad Science Holding Corp.'s Chief Accounting Officer, Alexis Gil II, sold 2,784 shares of common stock to cover tax liabilities from restricted stock unit settlement.
NASDAQ
Integral Ad Science CEO Lisa Utzschneider sold 9,922 shares of common stock to cover tax obligations from stock unit settlement.
NASDAQ
Integral Ad Science CEO Lisa Utzschneider acquired 19,448 shares of common stock through the vesting of market stock units.
NASDAQ
Integral Ad Science Holding Corp. CEO Lisa Utzschneider sold 8,285 shares of common stock on July 10, 2025, as a mandatory transaction to cover tax liabilities associated with the settlement of market stock units.
NASDAQ
Integral Ad Science Holding Corp. CEO Lisa Utzschneider sold 14,904 shares of common stock on July 8, 2025, to cover tax liabilities related to the settlement of market stock units.
NASDAQ
Integral Ad Science Holding Corp.'s Chief Accounting Officer, Alexis Gil II, sold 1,962 shares of common stock on July 7, 2025, to cover tax liabilities from restricted stock unit settlement.
NASDAQ
Integral Ad Science Holding Corp.'s CEO and Director, Lisa Utzschneider, acquired 15,767 shares of common stock through the vesting of market stock units.
NASDAQ
Integral Ad Science Holding Corp. CEO Lisa Utzschneider acquired 28,879 shares of common stock through the vesting of market stock units, increasing her direct beneficial ownership.
NASDAQ
Integral Ad Science Holding Corp.'s Chief Financial Officer, Alpana Wegner, acquired 525,279 shares of common stock on July 1, 2025, as part of a pre-arranged plan.
NASDAQ
Jill Putman, a director at Integral Ad Science Holding Corp., forfeited 42,377 unvested Restricted Stock Units as she transitioned out of her role as Interim Chief Financial Officer.
NASDAQ
Integral Ad Science Holding Corp.'s Chief Accounting Officer, Alexis Gil II, sold 2,851 shares of common stock on June 3, 2025, at a weighted average price of $7.97 per share, primarily to cover tax liabilities associated with restricted stock unit settlement.
NASDAQ
Robert Lord, a director of Integral Ad Science Holding Corp., reports the acquisition and disposal of common stock and restricted stock units.